CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ketoxime
Accession: CHEBI:24983
browse the term
Definition: Oximes of ketones R2C=NOH (where R =/= H).
Synonyms: related_synonym: Formula=CHNOR2; SMILES=O\\N=C(\\[*])[*]; ketoximes
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases expression
ISO EXP
6-bromoindirubin-3'-oxime results in increased expression of and results in increased activity of ABCB1 protein 6-bromoindirubin-3'-oxime results in increased expression of ABCB1 mRNA 6-bromoindirubin-3'-oxime results in increased expression of ABCB1A mRNA; 6-bromoindirubin-3'-oxime results in increased expression of ABCB1A protein
CTD
PMID:18624906
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of ABCC2 mRNA; 6-bromoindirubin-3'-oxime results in increased expression of ABCC2 protein
CTD
PMID:18624906
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc4
ATP binding cassette subfamily C member 4
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of ABCC4 mRNA; 6-bromoindirubin-3'-oxime results in increased expression of ABCC4 protein
CTD
PMID:18624906
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcg2
ATP binding cassette subfamily G member 2
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of ABCG2 mRNA; 6-bromoindirubin-3'-oxime results in increased expression of ABCG2 protein
CTD
PMID:18624906
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
6-bromoindirubin-3'-oxime binds to and results in increased activity of AHR protein
CTD
PMID:26259606
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions
ISO
[sorafenib co-treated with 6-bromoindirubin-3'-oxime] affects the localization of AIFM1 protein
CTD
PMID:17991738
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of ALDH1 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of ALDH1 protein]
CTD
PMID:37116855
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of BAX protein
CTD
PMID:37116855
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of BCL2 protein
CTD
PMID:37116855
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in decreased cleavage of CASP3 protein
CTD
PMID:37116855
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in increased expression of CASP8 protein modified form]
CTD
PMID:28414160
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccnd1
cyclin D1
increases expression
ISO EXP
6-bromoindirubin-3'-oxime results in increased expression of CCND1 mRNA
CTD
PMID:18624906
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdh1
cadherin 1
multiple interactions
ISO
6-bromoindirubin-3'-oxime inhibits the reaction [Amiodarone results in increased expression of CDH1 protein]
CTD
PMID:26515726
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdx1
caudal type homeo box 1
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of CDX1 mRNA
CTD
PMID:27693483
NCBI chr18:54,472,587...54,490,913
Ensembl chr18:54,473,444...54,490,814
G
Ctnnb1
catenin beta 1
multiple interactions decreases phosphorylation increases expression
ISO
[6-bromoindirubin-3'-oxime co-treated with DHFR mRNA] affects the expression of CTNNB1 protein; broussochalcone A inhibits the reaction [6-bromoindirubin-3'-oxime results in increased expression of CTNNB1 protein]; Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein] [trametinib co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of CTNNB1 protein
CTD
PMID:18624906 PMID:19727391 PMID:26259606 PMID:31163223 PMID:37116855
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression multiple interactions
ISO
6-bromoindirubin-3'-oxime results in increased expression of CYP1A2 mRNA 6-bromoindirubin-3'-oxime results in increased expression of and results in increased activity of CYP1A2 protein
CTD
PMID:26259606
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of CYP26A1 mRNA
CTD
PMID:27693483
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
G
Ddx3x
DEAD-box helicase 3, X-linked
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to DDX3X protein]]; 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in decreased expression of DDX3X protein modified form]
CTD
PMID:28414160
NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168
G
Dhfr
dihydrofolate reductase
multiple interactions
ISO
[6-bromoindirubin-3'-oxime co-treated with DHFR mRNA] affects the expression of CTNNB1 protein
CTD
PMID:19727391
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Diablo
diablo, IAP-binding mitochondrial protein
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [sorafenib affects the localization of DIABLO protein]
CTD
PMID:17991738
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Gsk3a
glycogen synthase kinase 3 alpha
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in decreased expression of GSK3A protein modified form]
CTD
PMID:28414160
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
G
Gsk3b
glycogen synthase kinase 3 beta
decreases activity increases phosphorylation multiple interactions
ISO
6-bromoindirubin-3'-oxime results in decreased activity of GSK3B protein 6-bromoindirubin-3'-oxime results in increased phosphorylation of GSK3B protein 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat inhibits the reaction [TNFRSF10B protein binds to GSK3B protein]]; 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in decreased expression of GSK3B protein modified form]; Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in increased phosphorylation of GSK3B protein] [trametinib co-treated with 6-bromoindirubin-3'-oxime] affects the phosphorylation of GSK3B protein
CTD
PMID:17991738 PMID:19727391 PMID:28414160 PMID:37116855
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Hoxa1
homeobox A1
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of HOXA1 mRNA
CTD
PMID:27693483
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
G
Il6
interleukin 6
multiple interactions
ISO
[6-bromoindirubin-3'-oxime co-treated with Methotrexate] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:19727391
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Itga6
integrin subunit alpha 6
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of ITGA6 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of ITGA6 protein]
CTD
PMID:37116855
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
G
Krt17
keratin 17
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of KRT17 protein]
CTD
PMID:37116855
NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
increases expression
ISO
6-bromoindirubin-3'-oxime results in increased expression of LGR5 mRNA
CTD
PMID:26259606
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
6-bromoindirubin-3'-oxime results in decreased expression of MCL1 protein
CTD
PMID:17991738
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of MKI67 protein
CTD
PMID:37116855
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Nanog
Nanog homeobox
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of NANOG protein]
CTD
PMID:37116855
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in increased expression of PARP1 protein modified form]
CTD
PMID:28414160
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
multiple interactions
ISO
6-bromoindirubin-3'-oxime inhibits the reaction [sorafenib results in decreased expression of PMAIP1 protein]
CTD
PMID:17991738
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pou5f1
POU class 5 homeobox 1
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of POU5F1 mRNA [trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of POU5F1 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of POU5F1 protein]
CTD
PMID:27693483 PMID:37116855
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Sox2
SRY-box transcription factor 2
multiple interactions
ISO
[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of SOX2 protein; XAV939 inhibits the reaction [[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of SOX2 protein]
CTD
PMID:37116855
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[6-bromoindirubin-3'-oxime co-treated with Methotrexate] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:19727391
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Wnt3
Wnt family member 3
multiple interactions
ISO
[Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] results in decreased expression of WNT3 mRNA
CTD
PMID:27693483
NCBI chr10:88,680,198...88,724,170
Ensembl chr10:88,680,248...88,724,099
G
Slc22a6
solute carrier family 22 member 6
multiple interactions increases uptake
ISO
cefdinir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] SLC22A6 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
multiple interactions increases uptake
ISO
cefdinir inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] SLC22A8 protein results in increased uptake of cefdinir
CTD
PMID:16098483
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Ache
acetylcholinesterase
multiple interactions
ISO
diacetylmonoxime inhibits the reaction [cyclohexyl methylphosphonofluoridate binds to and results in decreased activity of ACHE protein]; diacetylmonoxime inhibits the reaction [Paraoxon binds to and results in decreased activity of ACHE protein]; diacetylmonoxime inhibits the reaction [Sarin binds to and results in decreased activity of ACHE protein]; diacetylmonoxime inhibits the reaction [tabun results in decreased activity of ACHE protein]; diacetylmonoxime inhibits the reaction [VX binds to and results in decreased activity of ACHE protein]
CTD
PMID:22960624 PMID:22975155
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acta2
actin alpha 2, smooth muscle
decreases expression affects localization
EXP ISO
diacetylmonoxime results in decreased expression of ACTA2 diacetylmonoxime affects the localization of ACTA2 protein
CTD
PMID:11591817 PMID:11868461
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Bche
butyrylcholinesterase
multiple interactions
EXP
diacetylmonoxime inhibits the reaction [Dichlorvos results in decreased activity of BCHE protein]; diacetylmonoxime inhibits the reaction [Isoflurophate results in decreased activity of BCHE protein]
CTD
PMID:1276991
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Casp3
caspase 3
multiple interactions
ISO
diacetylmonoxime inhibits the reaction [Demecolcine results in increased activity of CASP3 protein]
CTD
PMID:12530016
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
diacetylmonoxime results in decreased expression of CDKN1A protein
CTD
PMID:15252113
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
diacetylmonoxime results in increased expression of CDKN1B protein
CTD
PMID:15252113
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Myod1
myogenic differentiation 1
decreases expression
ISO
diacetylmonoxime results in decreased expression of MYOD1 protein
CTD
PMID:15252113
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
G
Myog
myogenin
decreases expression
ISO
diacetylmonoxime results in decreased expression of MYOG protein
CTD
PMID:15252113
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Tf
transferrin
decreases uptake
ISO
diacetylmonoxime results in decreased uptake of TF protein
CTD
PMID:16563724
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Actb
actin, beta
affects expression
ISO
indirubin-3'-monoxime affects the expression of ACTB protein
CTD
PMID:18958680
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Ahr
aryl hydrocarbon receptor
multiple interactions affects binding
ISO
AHR protein affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of CD86 protein]; AHR protein affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of ITGAX protein] indirubin-3'-monoxime binds to and results in increased activity of AHR protein indirubin-3'-monoxime binds to AHR protein
CTD
PMID:15001395 PMID:21948866
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions increases expression
ISO
Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of ALDH1A1 protein]
CTD
PMID:21948866
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of ALDH1A2 protein
CTD
PMID:21948866
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aqp9
aquaporin 9
multiple interactions
ISO
indirubin-3'-monoxime promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA]; indirubin-3'-monoxime promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein]
CTD
PMID:18344322
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Ar
androgen receptor
increases activity
ISO
indirubin-3'-monoxime analog results in increased activity of AR protein; indirubin-3'-monoxime results in increased activity of AR protein
CTD
PMID:21111724
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of BAX mRNA
CTD
PMID:18958680
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2L1 mRNA
CTD
PMID:18958680
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Casp8
caspase 8
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CASP8 mRNA
CTD
PMID:18958680
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cat
catalase
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CAT mRNA
CTD
PMID:18958680
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl4
C-C motif chemokine ligand 4
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CCL4 mRNA
CTD
PMID:18958680
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Cd40
CD40 molecule
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased expression of CD40 protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 protein] indirubin-3'-monoxime results in decreased expression of CD40 protein
CTD
PMID:21948866
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd80
Cd80 molecule
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of CD80 protein [Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in increased expression of CD80 protein; indirubin-3'-monoxime promotes the reaction [Lipopolysaccharides results in increased expression of CD80 protein]
CTD
PMID:21948866
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd86
CD86 molecule
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased expression of CD86 protein; AHR protein affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of CD86 protein]; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein]
CTD
PMID:21948866
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdk2
cyclin dependent kinase 2
decreases activity
ISO
indirubin-3'-monoxime results in decreased activity of CDK2 protein
CTD
PMID:12534346
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CDKN1A mRNA
CTD
PMID:18958680
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
ISO EXP
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CYP1A1 mRNA; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP1A1 mRNA; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP1A1 protein indirubin-3'-monoxime results in increased expression of CYP1A1 mRNA indirubin-3'-monoxime results in increased expression of CYP1A1 protein
CTD
PMID:15001395 PMID:18958680 PMID:21948866
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Ephx2
epoxide hydrolase 2
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of EPHX2 mRNA
CTD
PMID:18958680
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Gpx1
glutathione peroxidase 1
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of GPX1 mRNA
CTD
PMID:18958680
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gsk3b
glycogen synthase kinase 3 beta
decreases activity
ISO
indirubin-3'-monoxime results in decreased activity of GSK3B protein
CTD
PMID:12534346
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
indirubin-3'-monoxime results in increased expression of GSR mRNA
CTD
PMID:18958680
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HMOX1 mRNA
CTD
PMID:18958680
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspa2
heat shock protein family A (Hsp70) member 2
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA2 mRNA
CTD
PMID:18958680
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA6 mRNA
CTD
PMID:18958680
NCBI chr13:83,273,176...83,274,317
G
Hspa9
heat shock protein family A (Hsp70) member 9
multiple interactions increases expression
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA9 mRNA indirubin-3'-monoxime results in increased expression of HSPA9 mRNA
CTD
PMID:18958680
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
G
Icam1
intercellular adhesion molecule 1
multiple interactions decreases expression
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased expression of ICAM1 protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] indirubin-3'-monoxime results in decreased expression of ICAM1 protein
CTD
PMID:21948866
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ido1
indoleamine 2,3-dioxygenase 1
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of IDO1 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of IDO1 protein]
CTD
PMID:21948866
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
G
Ido2
indoleamine 2,3-dioxygenase 2
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of IDO2 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of IDO2 protein]
CTD
PMID:21948866
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
G
Ifng
interferon gamma
decreases secretion
ISO
indirubin-3'-monoxime results in decreased secretion of IFNG protein
CTD
PMID:21948866
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
multiple interactions decreases secretion
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in increased secretion of IL10 protein; indirubin-3'-monoxime promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] indirubin-3'-monoxime results in decreased secretion of IL10 protein
CTD
PMID:21948866
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased secretion of IL1B protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:21948866
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
increases secretion
ISO
indirubin-3'-monoxime results in increased secretion of IL2 protein
CTD
PMID:21948866
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il27
interleukin 27
decreases expression multiple interactions
ISO
indirubin-3'-monoxime results in decreased expression of IL27 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of IL27 protein]
CTD
PMID:21948866
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Il6
interleukin 6
multiple interactions
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased expression of IL6 protein; [Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased secretion of IL6 protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:21948866
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Itgax
integrin subunit alpha X
multiple interactions decreases expression
ISO
AHR protein affects the susceptibility to [indirubin-3'-monoxime results in decreased expression of ITGAX protein]; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAX protein]
CTD
PMID:21948866
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Klk1c10
kallikrein 1-related peptidase C10
increases expression
ISO
indirubin-3'-monoxime analog results in increased expression of KLK3 mRNA; indirubin-3'-monoxime results in increased expression of KLK3 mRNA
CTD
PMID:21111724
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Lck
LCK proto-oncogene, Src family tyrosine kinase
decreases activity
ISO
indirubin-3'-monoxime results in decreased activity of LCK protein
CTD
PMID:12534346
NCBI chr 5:141,888,318...141,916,945
Ensembl chr 5:141,888,326...141,903,794
G
Mt2A
metallothionein 2A
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MT2A mRNA
CTD
PMID:18958680
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of NFKBIA mRNA
CTD
PMID:18958680
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA; [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein
CTD
PMID:18958680
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
indirubin-3'-monoxime results in decreased expression of RAD23A mRNA
CTD
PMID:18958680
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases activity
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in increased activity of RELA protein indirubin-3'-monoxime results in decreased activity of RELA protein
CTD
PMID:21948866
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SERPINE1 mRNA
CTD
PMID:18958680
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Sgk1
serum/glucocorticoid regulated kinase 1
decreases activity
ISO
indirubin-3'-monoxime results in decreased activity of SGK1 protein
CTD
PMID:12534346
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
[indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOD2 mRNA
CTD
PMID:18958680
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tgfb2
transforming growth factor, beta 2
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of TGFB2 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of TGFB2 protein]
CTD
PMID:21948866
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Tgfb3
transforming growth factor, beta 3
increases expression multiple interactions
ISO
indirubin-3'-monoxime results in increased expression of TGFB3 protein Lipopolysaccharides affects the susceptibility to [indirubin-3'-monoxime results in increased expression of TGFB3 protein]
CTD
PMID:21948866
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Lipopolysaccharides co-treated with indirubin-3'-monoxime] results in decreased secretion of TNF protein; indirubin-3'-monoxime inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:21948866
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ung
uracil-DNA glycosylase
increases expression
ISO
indirubin-3'-monoxime results in increased expression of UNG mRNA
CTD
PMID:18958680
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
G
Aars1
alanyl-tRNA synthetase 1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of AARS mRNA
CTD
PMID:37748715
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
G
Abcf3
ATP binding cassette subfamily F member 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ABCF3 mRNA
CTD
PMID:37748715
NCBI chr11:80,340,476...80,352,211
Ensembl chr11:80,339,977...80,352,211
G
Ace
angiotensin I converting enzyme
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ACE mRNA
CTD
PMID:37748715
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adap2
ArfGAP with dual PH domains 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADAP2 mRNA
CTD
PMID:37748715
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
G
Adgra2
adhesion G protein-coupled receptor A2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRA2 mRNA
CTD
PMID:37748715
NCBI chr16:64,932,964...64,971,433
Ensembl chr16:64,933,315...64,971,483
G
Adgra3
adhesion G protein-coupled receptor A3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRA3 mRNA
CTD
PMID:37748715
NCBI chr14:60,874,719...60,976,341
Ensembl chr14:60,874,715...60,976,332
G
Adgrg1
adhesion G protein-coupled receptor G1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ADGRG1 mRNA
CTD
PMID:37748715
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
G
Akirin1
akirin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AKIRIN1 mRNA
CTD
PMID:37748715
NCBI chr 5:135,989,378...136,004,782
Ensembl chr 5:135,989,465...136,004,762
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of ALDH18A1 mRNA
CTD
PMID:37748715
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Alkbh5
alkB homolog 5, RNA demethylase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ALKBH5 mRNA
CTD
PMID:37748715
NCBI chr10:45,344,888...45,366,331
Ensembl chr10:45,343,395...45,366,331
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of APBB1IP mRNA
CTD
PMID:37748715
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
G
Apela
apelin receptor early endogenous ligand
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of APELA mRNA
CTD
PMID:37748715
NCBI chr16:24,694,356...24,703,466
Ensembl chr16:24,694,324...24,703,465
G
Arih2
ariadne RBR E3 ubiquitin protein ligase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARIH2 mRNA
CTD
PMID:37748715
NCBI chr 8:109,296,738...109,355,909
Ensembl chr 8:109,296,738...109,355,852
G
Arl14ep
ARF like GTPase 14 effector protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARL14EP mRNA
CTD
PMID:37748715
NCBI chr 3:93,441,952...93,454,282
Ensembl chr 3:93,443,183...93,454,155
G
Arnt
aryl hydrocarbon receptor nuclear translocator
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARNT mRNA
CTD
PMID:37748715
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Arrdc4
arrestin domain containing 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ARRDC4 mRNA
CTD
PMID:37748715
NCBI chr 1:122,369,355...122,383,351
Ensembl chr 1:122,369,360...122,383,290
G
Asb8
ankyrin repeat and SOCS box-containing 8
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ASB8 mRNA
CTD
PMID:37748715
NCBI chr 7:129,261,397...129,297,492
Ensembl chr 7:129,261,397...129,297,485
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of ASNS mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of ASNS mRNA]
CTD
PMID:37748715
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Ate1
arginyltransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATE1 mRNA
CTD
PMID:37748715
NCBI chr 1:184,961,548...185,081,112
Ensembl chr 1:184,963,562...185,080,908
G
Atf2
activating transcription factor 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF2 mRNA
CTD
PMID:37748715
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Atf3
activating transcription factor 3
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of ATF3 mRNA
CTD
PMID:37748715
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF4 mRNA
CTD
PMID:37748715
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atf5
activating transcription factor 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF5 mRNA
CTD
PMID:37748715
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atf6
activating transcription factor 6
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ATF6 mRNA
CTD
PMID:37748715
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Aup1
AUP1, lipid droplet regulating VLDL assembly factor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AUP1 mRNA
CTD
PMID:37748715
NCBI chr 4:115,560,274...115,563,346
Ensembl chr 4:115,560,261...115,563,346
G
Avil
advillin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of AVIL mRNA
CTD
PMID:37748715
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
G
B3galnt1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of B3GALNT1 mRNA
CTD
PMID:37748715
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
G
Bbx
BBX high mobility group box domain containing
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BBX mRNA
CTD
PMID:37748715
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BGLAP mRNA
CTD
PMID:37748715
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Brms1l
BRMS1 like transcriptional repressor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of BRMS1L mRNA
CTD
PMID:37748715
NCBI chr 6:73,266,673...73,300,630
Ensembl chr 6:73,266,691...73,300,631
G
Calml4
calmodulin-like 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CALML4 mRNA
CTD
PMID:37748715
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CARHSP1 mRNA
CTD
PMID:37748715
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
G
Carmil1
capping protein regulator and myosin 1 linker 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CARMIL1 mRNA
CTD
PMID:37748715
NCBI chr17:40,807,921...41,088,326
Ensembl chr17:40,808,389...41,088,326
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of CARS mRNA
CTD
PMID:37748715
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Cbx7
chromobox 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CBX7 mRNA
CTD
PMID:37748715
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Ccnb2
cyclin B2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CCNB2 mRNA
CTD
PMID:37748715
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Cd68
Cd68 molecule
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CD68 mRNA
CTD
PMID:37748715
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CDCA3 mRNA
CTD
PMID:37748715
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cebpg
CCAAT/enhancer binding protein gamma
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CEBPG mRNA
CTD
PMID:37748715
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
G
Cep170
centrosomal protein 170
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CEP170 mRNA
CTD
PMID:37748715
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of CHAC1 mRNA]
CTD
PMID:37748715
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Coa7
cytochrome c oxidase assembly factor 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COA7 mRNA
CTD
PMID:37748715
NCBI chr 5:123,069,356...123,080,942
Ensembl chr 5:123,069,371...123,080,199
G
Commd5
COMM domain containing 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COMMD5 mRNA
CTD
PMID:37748715
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
G
Cox6a2
cytochrome c oxidase subunit 6A2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of COX6A2 mRNA
CTD
PMID:37748715
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
G
Cpt1a
carnitine palmitoyltransferase 1A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CPT1A mRNA
CTD
PMID:37748715
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cryzl1
crystallin zeta like 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CRYZL1 mRNA
CTD
PMID:37748715
NCBI chr11:30,933,140...30,977,936
Ensembl chr11:30,933,144...30,977,867
G
Csf3r
colony stimulating factor 3 receptor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CSF3R mRNA
CTD
PMID:37748715
NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881
G
Ctps2
CTP synthase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of CTPS2 mRNA
CTD
PMID:37748715
NCBI chr X:31,645,873...31,786,733
Ensembl chr X:31,645,873...31,786,733
G
Cyb5b
cytochrome b5 type B
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine; [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
G
Cyb5r3
cytochrome b5 reductase 3
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine; [CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
G
Dcaf15
DDB1 and CUL4 associated factor 15
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DCAF15 mRNA
CTD
PMID:37748715
NCBI chr19:24,053,925...24,061,277
Ensembl chr19:24,053,925...24,061,277
G
Ddhd2
DDHD domain containing 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDHD2 mRNA
CTD
PMID:37748715
NCBI chr16:66,319,469...66,349,025
Ensembl chr16:66,319,466...66,349,023
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of DDIT3 mRNA]
CTD
PMID:37748715
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of DDIT4 mRNA
CTD
PMID:37748715
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddx19b
DEAD-box helicase 19B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDX19B mRNA
CTD
PMID:37748715
NCBI chr19:38,968,215...38,998,907
Ensembl chr19:38,968,215...38,997,259
G
Ddx4
DEAD-box helicase 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DDX4 mRNA
CTD
PMID:37748715
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
G
Def8
differentially expressed in FDCP 8 homolog
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DEF8 mRNA
CTD
PMID:37748715
NCBI chr19:51,474,783...51,495,638
Ensembl chr19:51,474,878...51,495,638
G
Dnajc5g
DnaJ heat shock protein family (Hsp40) member C5 gamma
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DNAJC5G mRNA
CTD
PMID:37748715
NCBI chr 6:25,260,087...25,264,251
Ensembl chr 6:25,260,088...25,264,152
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DNMT1 mRNA
CTD
PMID:37748715
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dusp11
dual specificity phosphatase 11
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP11 mRNA
CTD
PMID:37748715
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
G
Dusp16
dual specificity phosphatase 16
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP16 mRNA
CTD
PMID:37748715
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp19
dual specificity phosphatase 19
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DUSP19 mRNA
CTD
PMID:37748715
NCBI chr 3:65,538,424...65,554,465
Ensembl chr 3:65,538,420...65,553,534
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DYNLL1 mRNA
CTD
PMID:37748715
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Dyrk4
dual specificity tyrosine phosphorylation regulated kinase 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of DYRK4 mRNA
CTD
PMID:37748715
NCBI chr 4:159,715,658...159,757,660
Ensembl chr 4:159,715,417...159,757,627
G
E2f8
E2F transcription factor 8
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of E2F8 mRNA
CTD
PMID:37748715
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EIF4EBP1 mRNA
CTD
PMID:37748715
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ELF1 mRNA
CTD
PMID:37748715
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
G
Emc9
ER membrane protein complex subunit 9
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EMC9 mRNA
CTD
PMID:37748715
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
G
Enpep
glutamyl aminopeptidase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ENPEP mRNA
CTD
PMID:37748715
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
G
Epb41l5
erythrocyte membrane protein band 4.1 like 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of EPB41L5 mRNA
CTD
PMID:37748715
NCBI chr13:30,670,792...30,770,213
Ensembl chr13:30,669,764...30,768,360
G
Exosc6
exosome component 6
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of EXOSC6 mRNA
CTD
PMID:37748715
NCBI chr19:39,022,171...39,023,585
Ensembl chr19:39,022,183...39,023,515
G
Fam98a
family with sequence similarity 98, member A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FAM98A mRNA
CTD
PMID:37748715
NCBI chr 6:19,874,082...19,888,744
Ensembl chr 6:19,874,071...19,888,742
G
Fanca
FA complementation group A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FANCA mRNA
CTD
PMID:37748715
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
G
Fbxl12
F-box and leucine-rich repeat protein 12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FBXL12 mRNA
CTD
PMID:37748715
NCBI chr 8:19,175,864...19,183,373
Ensembl chr 8:19,160,352...19,183,607
G
Fbxo5
F-box protein 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FBXO5 mRNA
CTD
PMID:37748715
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fetub
fetuin B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FETUB mRNA
CTD
PMID:37748715
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
G
Fhip2b
FHF complex subunit HOOK interacting protein 2B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FHIP2B mRNA
CTD
PMID:37748715
NCBI chr15:45,656,641...45,674,603
Ensembl chr15:45,656,647...45,674,105
G
Foxk2
forkhead box K2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FOXK2 mRNA
CTD
PMID:37748715
NCBI chr10:106,542,643...106,592,569
Ensembl chr10:106,542,566...106,592,563
G
Fzd4
frizzled class receptor 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of FZD4 mRNA
CTD
PMID:37748715
NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GADD45A mRNA
CTD
PMID:37748715
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GARS mRNA
CTD
PMID:37748715
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GAS2 mRNA
CTD
PMID:37748715
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gdf15
growth differentiation factor 15
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GDF15 mRNA
CTD
PMID:37748715
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gid4
GID complex subunit 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GID4 mRNA
CTD
PMID:37748715
NCBI chr10:45,221,556...45,247,627
Ensembl chr10:45,245,754...45,247,621 Ensembl chr10:45,245,754...45,247,621
G
Glb1
galactosidase, beta 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GLB1 mRNA
CTD
PMID:37748715
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Gpt2
glutamic--pyruvic transaminase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GPT2 mRNA
CTD
PMID:37748715
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
G
Grb10
growth factor receptor bound protein 10
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of GRB10 mRNA
CTD
PMID:37748715
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
G
Grcc10
gene rich cluster, C10 gene
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of GRCC10 mRNA
CTD
PMID:37748715
NCBI chr 4:157,551,276...157,552,924
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HADHA mRNA
CTD
PMID:37748715
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HADHB mRNA
CTD
PMID:37748715
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
G
Hax1
HCLS1 associated protein X-1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HAX1 mRNA
CTD
PMID:37748715
NCBI chr 2:175,434,242...175,437,926
Ensembl chr 2:175,434,238...175,437,714
G
Helz
helicase with zinc finger
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HELZ mRNA
CTD
PMID:37748715
NCBI chr10:92,479,403...92,645,234
Ensembl chr10:92,501,518...92,638,383
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of HERPUD1 mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of HERPUD1 mRNA]
CTD
PMID:37748715
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Herpud2
HERPUD family member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HERPUD2 mRNA
CTD
PMID:37748715
NCBI chr 8:23,573,374...23,618,380
Ensembl chr 8:23,573,379...23,617,874
G
Hexa
hexosaminidase subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HEXA mRNA
CTD
PMID:37748715
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
G
Hexim1
HEXIM P-TEFb complex subunit 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HEXIM1 mRNA
CTD
PMID:37748715
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189
G
Hmox1
heme oxygenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of HMOX1 mRNA
CTD
PMID:37748715
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Iars1
isoleucyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IARS mRNA
CTD
PMID:37748715
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ID2 mRNA
CTD
PMID:37748715
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Inip
INTS3 and NABP interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of INIP mRNA
CTD
PMID:37748715
NCBI chr 5:74,648,392...74,662,628
Ensembl chr 5:74,648,392...74,662,628
G
Irak1bp1
interleukin-1 receptor-associated kinase 1 binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IRAK1BP1 mRNA
CTD
PMID:37748715
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of IRF2BP2 mRNA
CTD
PMID:37748715
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
G
Jam3
junctional adhesion molecule 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of JAM3 mRNA
CTD
PMID:37748715
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Jdp2
Jun dimerization protein 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of JDP2 mRNA
CTD
PMID:37748715
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Lgals1
galectin 1
multiple interactions decreases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of LGALS1 mRNA]
CTD
PMID:37748715
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lig1
DNA ligase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LIG1 mRNA
CTD
PMID:37748715
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lrfn1
leucine rich repeat and fibronectin type III domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LRFN1 mRNA
CTD
PMID:37748715
NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449
G
Lyrm7
LYR motif containing 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of LYRM7 mRNA
CTD
PMID:37748715
NCBI chr10:38,964,299...38,983,628
Ensembl chr10:38,964,311...38,983,601
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MAP2K5 mRNA
CTD
PMID:37748715
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MAPRE3 mRNA
CTD
PMID:37748715
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MCAM mRNA
CTD
PMID:37748715
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mdh1
malate dehydrogenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MDH1 mRNA
CTD
PMID:37748715
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Midn
midnolin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MIDN mRNA
CTD
PMID:37748715
NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
G
Mknk1
MAPK interacting serine/threonine kinase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MKNK1 mRNA
CTD
PMID:37748715
NCBI chr 5:129,318,128...129,357,641
Ensembl chr 5:129,318,170...129,357,639
G
Mob4
MOB family member 4, phocein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MOB4 mRNA
CTD
PMID:37748715
NCBI chr 9:56,617,374...56,641,336
Ensembl chr 9:56,617,368...56,641,329
G
Mrps12
mitochondrial ribosomal protein S12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MRPS12 mRNA
CTD
PMID:37748715
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
G
Mrps27
mitochondrial ribosomal protein S27
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MRPS27 mRNA
CTD
PMID:37748715
NCBI chr 2:30,740,007...30,808,577
Ensembl chr 2:30,740,033...30,808,577
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MSMO1 mRNA
CTD
PMID:37748715
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Mt2A
metallothionein 2A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MT2 mRNA
CTD
PMID:37748715
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtarc1
mitochondrial amidoxime reducing component 1
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC1 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
G
Mtarc2
mitochondrial amidoxime reducing component 2
multiple interactions
ISO
[CYB5B protein co-treated with CYB5R3 protein co-treated with MTARC2 protein] results in increased reduction of N(4)-hydroxycytidine
CTD
PMID:22924387
NCBI chr13:96,362,810...96,397,284
G
Mtbp
MDM2 binding protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTBP mRNA
CTD
PMID:37748715
NCBI chr 7:86,973,215...87,055,775
Ensembl chr 7:86,973,069...87,050,827
G
Mthfd1l
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTHFD1L mRNA
CTD
PMID:37748715
NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of MTHFD2 mRNA]
CTD
PMID:37748715
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mtx1
Metaxin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MTX1 mRNA
CTD
PMID:37748715
NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:174,615,461...174,620,982
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of MYC mRNA
CTD
PMID:37748715
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nabp1
nucleic acid binding protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NABP1 mRNA
CTD
PMID:37748715
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
G
Nars1
asparaginyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NARS mRNA
CTD
PMID:37748715
NCBI chr18:57,989,308...58,005,584
Ensembl chr18:57,989,308...58,005,622
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCAPD2 mRNA
CTD
PMID:37748715
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCAPG mRNA
CTD
PMID:37748715
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NCOR1 mRNA
CTD
PMID:37748715
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
G
Nectin1
nectin cell adhesion molecule 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PVRL1 mRNA
CTD
PMID:37748715
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NSF mRNA
CTD
PMID:37748715
NCBI chr10:88,727,912...88,857,375
Ensembl chr10:88,727,912...88,857,386
G
Nsun3
NOP2/Sun RNA methyltransferase 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NSUN3 mRNA
CTD
PMID:37748715
NCBI chr11:37,490,832...37,575,607
Ensembl chr11:37,490,838...37,568,543
G
Ntaq1
N-terminal glutamine amidase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of WDYHV1 mRNA
CTD
PMID:37748715
NCBI chr 7:89,684,318...89,704,484
Ensembl chr 7:89,684,323...89,704,474
G
Nup85
nucleoporin 85
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of NUP85 mRNA
CTD
PMID:37748715
NCBI chr10:100,806,482...100,825,029
Ensembl chr10:100,806,437...100,825,043
G
Nupr1
nuclear protein 1, transcriptional regulator
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of NUPR1 mRNA]
CTD
PMID:37748715
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Nxf7
nuclear RNA export factor 7
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of NXF2 mRNA
CTD
PMID:37748715
NCBI chr X:98,535,374...98,552,562
Ensembl chr X:98,535,375...98,552,526
G
Ogdh
oxoglutarate dehydrogenase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OGDH mRNA
CTD
PMID:37748715
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
G
Oip5
Opa interacting protein 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OIP5 mRNA
CTD
PMID:37748715
NCBI chr 3:106,593,746...106,603,281
Ensembl chr 3:106,593,760...106,603,250
G
Optn
optineurin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OPTN mRNA
CTD
PMID:37748715
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
G
Osgepl1
O-sialoglycoprotein endopeptidase-like 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of OSGEPL1 mRNA
CTD
PMID:37748715
NCBI chr 9:48,214,995...48,229,440
Ensembl chr 9:48,215,402...48,229,388
G
P2rx3
purinergic receptor P2X 3
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of P2RX3 mRNA
CTD
PMID:37748715
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
G
P2rx7
purinergic receptor P2X 7
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of P2RX7 mRNA
CTD
PMID:37748715
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
P4ha2
prolyl 4-hydroxylase subunit alpha 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of P4HA2 mRNA
CTD
PMID:37748715
NCBI chr10:38,243,136...38,271,983
Ensembl chr10:38,243,139...38,287,314
G
Pak2
p21 (RAC1) activated kinase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PAK2 mRNA
CTD
PMID:37748715
NCBI chr11:68,707,940...68,768,816
Ensembl chr11:68,707,969...68,768,816
G
Pde3a
phosphodiesterase 3A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDE3A mRNA
CTD
PMID:37748715
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
G
Pde4dip
phosphodiesterase 4D interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDE4DIP mRNA
CTD
PMID:37748715
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
G
Pds5b
PDS5 cohesin associated factor B
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PDS5B mRNA
CTD
PMID:37748715
NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596
G
Pex1
peroxisomal biogenesis factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PEX1 mRNA
CTD
PMID:37748715
NCBI chr 4:30,519,950...30,558,953
Ensembl chr 4:30,519,955...30,558,921
G
Pgam2
phosphoglycerate mutase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PGAM2 mRNA
CTD
PMID:37748715
NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940
G
Pgp
phosphoglycolate phosphatase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PGP mRNA
CTD
PMID:37748715
NCBI chr10:13,495,232...13,497,858
Ensembl chr10:13,494,291...13,497,858
G
Pmch
pro-melanin-concentrating hormone
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PMCH mRNA
CTD
PMID:37748715
NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250
G
Polr2a
RNA polymerase II subunit A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of POLR2A mRNA
CTD
PMID:37748715
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PPP1R15A mRNA
CTD
PMID:37748715
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PPP1R3C mRNA
CTD
PMID:37748715
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PSAT1 mRNA
CTD
PMID:37748715
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psph
phosphoserine phosphatase
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of PSPH mRNA
CTD
PMID:37748715
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of PTK2 mRNA
CTD
PMID:37748715
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Rab21
RAB21, member RAS oncogene family
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RAB21 mRNA
CTD
PMID:37748715
NCBI chr 7:50,904,050...50,928,890
Ensembl chr 7:50,904,057...50,928,839
G
Rabggta
Rab geranylgeranyltransferase subunit alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RABGGTA mRNA
CTD
PMID:37748715
NCBI chr15:29,206,328...29,213,398
Ensembl chr15:29,206,157...29,213,348
G
Rad54l
RAD54 like
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RAD54L mRNA
CTD
PMID:37748715
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Reep6
receptor accessory protein 6
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of REEP6 mRNA
CTD
PMID:37748715
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Rfc2
replication factor C subunit 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RFC2 mRNA
CTD
PMID:37748715
NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557
G
Rhbdd1
rhomboid domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RHBDD1 mRNA
CTD
PMID:37748715
NCBI chr 9:83,630,037...83,748,690
Ensembl chr 9:83,630,063...83,748,689
G
Rragc
Ras-related GTP binding C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RRAGC mRNA
CTD
PMID:37748715
NCBI chr 5:136,148,239...136,167,773
Ensembl chr 5:136,148,276...136,167,767
G
Rspry1
ring finger and SPRY domain containing 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of RSPRY1 mRNA
CTD
PMID:37748715
NCBI chr19:10,352,449...10,403,015
Ensembl chr19:10,353,821...10,401,102
G
Samm50
SAMM50 sorting and assembly machinery component
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SAMM50 mRNA
CTD
PMID:37748715
NCBI chr 7:115,317,472...115,341,682
Ensembl chr 7:115,317,404...115,341,682
G
Sars1
seryl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SARS mRNA
CTD
PMID:37748715
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
G
Sema6a
semaphorin 6A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SEMA6A mRNA
CTD
PMID:37748715
NCBI chr18:40,050,623...40,171,954
Ensembl chr18:40,050,624...40,171,954
G
Sesn1
sestrin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SESN1 mRNA
CTD
PMID:37748715
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Sesn2
sestrin 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SESN2 mRNA
CTD
PMID:37748715
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sh3tc1
SH3 domain and tetratricopeptide repeats 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SH3TC1 mRNA
CTD
PMID:37748715
NCBI chr14:75,005,691...75,050,001
Ensembl chr14:75,016,875...75,049,995
G
Shmt2
serine hydroxymethyltransferase 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SHMT2 mRNA
CTD
PMID:37748715
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
G
Ska2
spindle and kinetochore associated complex subunit 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SKA2 mRNA
CTD
PMID:37748715
NCBI chr10:71,921,474...71,939,461
Ensembl chr10:71,921,582...71,939,458
G
Slc1a4
solute carrier family 1 member 4
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of SLC1A4 mRNA
CTD
PMID:37748715
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc1a5
solute carrier family 1 member 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC1A5 mRNA
CTD
PMID:37748715
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc25a31
solute carrier family 25 member 31
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A31 mRNA
CTD
PMID:37748715
NCBI chr 2:123,695,387...123,711,275
Ensembl chr 2:123,695,408...123,710,795
G
Slc25a36
solute carrier family 25 member 36
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A36 mRNA
CTD
PMID:37748715
NCBI chr 8:97,659,848...97,693,735
Ensembl chr 8:97,662,127...97,693,703
G
Slc25a4
solute carrier family 25 member 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC25A4 mRNA
CTD
PMID:37748715
NCBI chr16:46,072,935...46,076,730
Ensembl chr16:46,072,939...46,076,733
G
Slc26a2
solute carrier family 26 member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC26A2 mRNA
CTD
PMID:37748715
NCBI chr18:54,648,276...54,666,627
Ensembl chr18:54,652,951...54,666,626
G
Slc2a1
solute carrier family 2 member 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC2A1 mRNA
CTD
PMID:37748715
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc35a4
solute carrier family 35, member A4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC35A4 mRNA
CTD
PMID:37748715
NCBI chr18:28,280,483...28,284,610
Ensembl chr18:28,279,750...28,284,725
G
Slc38a1
solute carrier family 38, member 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A1 mRNA
CTD
PMID:37748715
NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218
G
Slc38a2
solute carrier family 38, member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A2 mRNA
CTD
PMID:37748715
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc38a7
solute carrier family 38, member 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC38A7 mRNA
CTD
PMID:37748715
NCBI chr19:9,209,203...9,225,472
Ensembl chr19:9,209,257...9,225,454
G
Slc39a4
solute carrier family 39 member 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC39A4 mRNA
CTD
PMID:37748715
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc3a2
solute carrier family 3 member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC3A2 mRNA
CTD
PMID:37748715
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc44a4
solute carrier family 44, member 4
multiple interactions decreases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in decreased expression of SLC44A4 mRNA]
CTD
PMID:37748715
NCBI chr20:3,903,099...3,919,215
Ensembl chr20:3,903,099...3,919,215
G
Slc6a9
solute carrier family 6 member 9
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC6A9 mRNA
CTD
PMID:37748715
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slc7a1
solute carrier family 7 member 1
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of SLC7A1 mRNA]
CTD
PMID:37748715
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc7a3
solute carrier family 7 member 3
increases expression
ISO
N(4)-hydroxycytidine results in increased expression of SLC7A3 mRNA
CTD
PMID:37748715
NCBI chr X:66,210,071...66,216,482
Ensembl chr X:66,210,081...66,215,708
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC7A5 mRNA
CTD
PMID:37748715
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slc7a7
solute carrier family 7 member 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SLC7A7 mRNA
CTD
PMID:37748715
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Smcr8
SMCR8-C9orf72 complex subunit
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SMCR8 mRNA
CTD
PMID:37748715
NCBI chr10:45,457,962...45,465,101
Ensembl chr10:45,457,605...45,468,876
G
Smim22
small integral membrane protein 22
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SMIM22 mRNA
CTD
PMID:37748715
NCBI chr10:10,572,146...10,574,339
G
Snord1c
small nucleolar RNA, C/D box 1C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SNORD1C mRNA
CTD
PMID:37748715
NCBI chr10:101,905,797...101,905,872
Ensembl chr10:101,905,797...101,905,872
G
Snx4
sorting nexin 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SNX4 mRNA
CTD
PMID:37748715
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Spag7
sperm associated antigen 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SPAG7 mRNA
CTD
PMID:37748715
NCBI chr10:55,377,249...55,383,404
Ensembl chr10:55,377,249...55,383,404
G
Sqle
squalene epoxidase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SQLE mRNA
CTD
PMID:37748715
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srxn1
sulfiredoxin 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SRXN1 mRNA
CTD
PMID:37748715
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Stc2
stanniocalcin 2
multiple interactions increases expression
ISO
4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of STC2 mRNA]
CTD
PMID:37748715
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stil
STIL, centriolar assembly protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of STIL mRNA
CTD
PMID:37748715
NCBI chr 5:128,520,837...128,573,732
Ensembl chr 5:128,520,953...128,573,730
G
Stx7
syntaxin 7
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of STX7 mRNA
CTD
PMID:37748715
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Svil
supervillin
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SVIL mRNA
CTD
PMID:37748715
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
G
Sycp1
synaptonemal complex protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of SYCP1 mRNA
CTD
PMID:37748715
NCBI chr 2:190,296,688...190,456,687
Ensembl chr 2:190,296,954...190,456,737
G
Tars1
threonyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TARS mRNA
CTD
PMID:37748715
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
G
Tas2r108
taste receptor, type 2, member 108
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TAS2R108 mRNA
CTD
PMID:37748715
NCBI chr 4:69,287,667...69,288,581
Ensembl chr 4:69,287,667...69,288,581
G
Tat
tyrosine aminotransferase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TAT mRNA
CTD
PMID:37748715
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tbcc
tubulin folding cofactor C
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TBCC mRNA
CTD
PMID:37748715
NCBI chr 9:14,098,855...14,100,043
Ensembl chr 9:14,098,868...14,100,042
G
Tdg
thymine-DNA glycosylase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TDG mRNA
CTD
PMID:37748715
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
G
Tec
tec protein tyrosine kinase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TEC mRNA
CTD
PMID:37748715
NCBI chr14:35,352,551...35,461,585
Ensembl chr14:35,352,829...35,461,557
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TERF1 mRNA
CTD
PMID:37748715
NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340
G
Thap4
THAP domain containing 4
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of THAP4 mRNA
CTD
PMID:37748715
NCBI chr 9:94,242,581...94,282,312
Ensembl chr 9:94,242,581...94,282,306
G
Tmppe
transmembrane protein with metallophosphoesterase domain
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TMPPE mRNA
CTD
PMID:37748715
NCBI chr 8:114,085,497...114,093,388
Ensembl chr 8:114,084,831...114,094,286
G
Top2a
DNA topoisomerase II alpha
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TOP2A mRNA
CTD
PMID:37748715
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tor1aip1
torsin 1A interacting protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TOR1AIP1 mRNA
CTD
PMID:37748715
NCBI chr13:68,196,681...68,226,121
Ensembl chr13:68,196,681...68,225,862
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRP53INP1 mRNA
CTD
PMID:37748715
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tpcn2
two pore segment channel 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TPCN2 mRNA
CTD
PMID:37748715
NCBI chr 1:200,416,538...200,446,252
Ensembl chr 1:200,416,540...200,446,236
G
Trib3
tribbles pseudokinase 3
increases expression multiple interactions
ISO
N(4)-hydroxycytidine results in increased expression of TRIB3 mRNA 4-nitrobenzylthioinosine inhibits the reaction [N(4)-hydroxycytidine results in increased expression of TRIB3 mRNA]
CTD
PMID:37748715
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim32
tripartite motif-containing 32
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRIM32 mRNA
CTD
PMID:37748715
NCBI chr 5:79,005,139...79,016,615
Ensembl chr 5:78,999,389...79,022,018
G
Trip12
thyroid hormone receptor interactor 12
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRIP12 mRNA
CTD
PMID:37748715
NCBI chr 9:85,916,691...86,043,312
Ensembl chr 9:85,916,691...86,051,403
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TRPM6 mRNA
CTD
PMID:37748715
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TUBB5 mRNA
CTD
PMID:37748715
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tug1
taurine up-regulated 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TUG1 mRNA
CTD
PMID:37748715
NCBI chr14:78,519,894...78,526,927
Ensembl chr14:78,522,506...78,526,927
G
Txnip
thioredoxin interacting protein
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of TXNIP mRNA
CTD
PMID:37748715
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Ugdh
UDP-glucose 6-dehydrogenase
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of UGDH mRNA
CTD
PMID:37748715
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Vangl1
VANGL planar cell polarity protein 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VANGL1 mRNA
CTD
PMID:37748715
NCBI chr 2:189,586,681...189,637,609
Ensembl chr 2:189,589,229...189,637,619
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VEGFA mRNA
CTD
PMID:37748715
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vtcn1
V-set domain containing T cell activation inhibitor 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of VTCN1 mRNA
CTD
PMID:37748715
NCBI chr 2:188,253,594...188,321,658
Ensembl chr 2:188,253,594...188,321,658
G
Wars1
tryptophanyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of WARS1 mRNA
CTD
PMID:37748715
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YARS mRNA
CTD
PMID:37748715
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Yipf2
Yip1 domain family, member 2
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YIPF2 mRNA
CTD
PMID:37748715
NCBI chr 8:20,141,148...20,145,349
Ensembl chr 8:20,141,155...20,145,339
G
Ypel5
yippee-like 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of YPEL5 mRNA
CTD
PMID:37748715
NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691
G
Zfp516
zinc finger protein 516
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ZFP516 mRNA
CTD
PMID:37748715
NCBI chr18:76,286,453...76,386,526
Ensembl chr18:76,302,096...76,385,269
G
Zswim5
zinc finger, SWIM-type containing 5
decreases expression
ISO
N(4)-hydroxycytidine results in decreased expression of ZSWIM5 mRNA
CTD
PMID:37748715
NCBI chr 5:130,346,733...130,463,791
Ensembl chr 5:130,343,034...130,463,784
G
Abcc2
ATP binding cassette subfamily C member 2
decreases activity
ISO
norgestimate results in decreased activity of ABCC2 protein
CTD
PMID:16049127
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Ar
androgen receptor
multiple interactions affects localization decreases expression
ISO
norgestimate binds to and results in decreased activity of AR protein; norgestimate binds to and results in increased activity of AR protein norgestimate affects the localization of AR protein norgestimate results in decreased expression of AR mRNA
CTD
PMID:17505938 PMID:28478275
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Crp
C-reactive protein
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of CRP protein
CTD
PMID:16982228
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein
CTD
PMID:16291717
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP2C19 protein
CTD
PMID:16291717
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
F7
coagulation factor VII
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F7 protein
CTD
PMID:12618251
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
F8
coagulation factor VIII
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F8 protein
CTD
PMID:12618251
NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857
G
Fga
fibrinogen alpha chain
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:12618251
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:12618251
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
G
Fgg
fibrinogen gamma chain
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:12618251
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Pgr
progesterone receptor
multiple interactions
ISO
norgestimate binds to and affects the activity of PGR protein
CTD
PMID:1324557 PMID:15697108
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Plat
plasminogen activator, tissue type
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PLAT protein; [Ethinyl Estradiol co-treated with norgestimate] results in increased activity of PLAT protein
CTD
PMID:12618251
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plg
plasminogen
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PLG protein
CTD
PMID:12618251
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PROC protein
CTD
PMID:12618251
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Pros1
protein S
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of PROS1 protein
CTD
PMID:12618251
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Serpina6
serpin family A member 6
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SERPINA6 protein
CTD
PMID:16982228
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
G
Serpina7
serpin family A member 7
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SERPINA7 protein
CTD
PMID:16982228
NCBI chr X:102,663,242...102,722,319
Ensembl chr X:102,663,405...102,669,040
G
Serpinc1
serpin family C member 1
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in decreased expression of SERPINC1 protein
CTD
PMID:12618251
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Shbg
sex hormone binding globulin
multiple interactions
ISO
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of SHBG protein
CTD
PMID:12586319 PMID:16982228
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Ache
acetylcholinesterase
decreases activity
EXP ISO
phoxim metabolite results in decreased activity of ACHE protein; phoxim results in decreased activity of ACHE protein
CTD
PMID:15793557 PMID:33497710 PMID:33844597
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ar
androgen receptor
multiple interactions
ISO
phoxim inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]
CTD
PMID:33049310
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arl6ip5
ARF like GTPase 6 interacting protein 5
affects expression
ISO
phoxim affects the expression of ARL6IP5 protein
CTD
PMID:15799245
NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
G
Bche
butyrylcholinesterase
decreases activity
EXP
phoxim metabolite results in decreased activity of BCHE protein
CTD
PMID:33497710
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression multiple interactions
ISO
phoxim results in increased expression of CEBPA protein Fulvestrant inhibits the reaction [phoxim results in increased expression of CEBPA protein]
CTD
PMID:33872936
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cldn4
claudin 4
decreases expression multiple interactions
EXP
phoxim results in decreased expression of CLDN4 mRNA Vitamin E inhibits the reaction [phoxim results in decreased expression of CLDN4 mRNA]
CTD
PMID:30003487
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
phoxim results in increased expression of CYP2B1 mRNA
CTD
PMID:36356836
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Esr1
estrogen receptor 1
multiple interactions affects binding
ISO
phoxim binds to and results in increased activity of ESR1 protein phoxim binds to ESR1 protein
CTD
PMID:33049310 PMID:33872936
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fas
Fas cell surface death receptor
increases expression multiple interactions
ISO
phoxim results in increased expression of FAS mRNA Fulvestrant inhibits the reaction [phoxim results in increased expression of FAS mRNA]
CTD
PMID:33872936
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Gpx2
glutathione peroxidase 2
increases expression multiple interactions
EXP
phoxim results in increased expression of GPX2 mRNA Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA]
CTD
PMID:30003487
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Il1b
interleukin 1 beta
decreases expression
EXP
phoxim results in decreased expression of IL1B mRNA
CTD
PMID:30003487
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
decreases expression multiple interactions
EXP
phoxim results in decreased expression of IL6 mRNA Vitamin E inhibits the reaction [phoxim results in decreased expression of IL6 mRNA]
CTD
PMID:30003487
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irs2
insulin receptor substrate 2
decreases expression
EXP
phoxim results in decreased expression of IRS2 mRNA
CTD
PMID:30090575
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
G
Lpl
lipoprotein lipase
increases expression multiple interactions
ISO
phoxim results in increased expression of LPL mRNA Fulvestrant inhibits the reaction [phoxim results in increased expression of LPL mRNA]
CTD
PMID:33872936
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
EXP
phoxim results in increased expression of NFE2L2 mRNA
CTD
PMID:30003487
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
phoxim binds to and results in increased activity of NR1I2 protein
CTD
PMID:33049310
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Ocln
occludin
multiple interactions decreases expression
EXP
Vitamin E inhibits the reaction [phoxim results in decreased expression of OCLN mRNA]
CTD
PMID:30003487
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Plin1
perilipin 1
multiple interactions increases expression
ISO
Fulvestrant inhibits the reaction [phoxim results in increased expression of PLIN1 protein]; tolclofos-methyl inhibits the reaction [phoxim results in increased expression of PLIN1 protein]
CTD
PMID:33872936
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
phoxim binds to and results in increased activity of PPARG protein phoxim results in increased expression of PPARG protein Fulvestrant inhibits the reaction [phoxim results in increased expression of PPARG protein]; phoxim binds to and results in increased activity of PPARG protein
CTD
PMID:33049310 PMID:33872936
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
phoxim binds to and results in decreased activity of THRA protein
CTD
PMID:33049310
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Tnf
tumor necrosis factor
multiple interactions increases expression
EXP
Vitamin E inhibits the reaction [phoxim results in increased expression of TNF protein] phoxim results in increased expression of TNF mRNA; phoxim results in increased expression of TNF protein
CTD
PMID:30003487
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
affects activity
ISO
phoxim metabolite affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19874
chemical entity
19872
atom
19872
nonmetal atom
19794
nitrogen atom
18974
nitrogen molecular entity
18974
oxime
429
ketoxime
353
(2E)-2-(hydroxyimino)isohexanoic acid
0
(2R,3R,4R,5S,6Z)-4,5-dihydroxy-6-(hydroxyimino)-2-(hydroxymethyl)piperidin-3-yl 4-O-methyl-alpha-D-maltoside
0
(2R,3R,4R,5S,6Z)-4,5-dihydroxy-6-(hydroxyimino)-2-(hydroxymethyl)piperidin-3-yl alpha-D-maltoside
0
(2Z,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-one oxime
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(E,E)-bastadin 19
0
(E,Z)-bastadin 19
0
(hydroxyimino)(phenyl)acetonitrile +
22
1-(4-chlorophenyl)-2-[5-(1-pyrrolidinyl)-2-tetrazolyl]ethanone oxime
0
1-(4-methyl-2-phenyl-5-thiazolyl)ethanone oxime
0
1-[9-ethyl-6-(1-hydroxyiminoethyl)-3-carbazolyl]ethanone oxime
0
11,11-dimethyl-4,8-dimethylenebicyclo[7.2.0]undecan-5-one oxime
0
2,6-diphenyl-3-propyl-4-piperidinone oxime
0
3,3-dimethyl-1-(methylsulfanyl)butan-2-one oxime +
0
3,4,5-trihydroxypiperidin-2-one oxime
0
3-(2-allyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime
0
3-(methylsulfanyl)butan-2-one oxime +
0
3-Oxopregn-4-ene-20beta-carboxaldehyde dioxime
0
3-allyloxyestra-1,3,5(10),7-tetraene-16,17-dione dioxime
0
4-hydroxyphenylpyruvic acid oxime
0
5-(hydroxyimino)-6-oxo-5,6-dihydronaphthalene-2-sulfonic acid
0
5-methylhexan-2-one oxime
0
6-bromoindirubin-3'-oxime
36
Buccoxime
0
Cyclopentan-1-one oxime
0
Exametazime
0
FIN56
0
FK409
0
GDC-0879
0
Labienoxime
0
N(4)-hydroxycytidine +
236
N-\{5-[2-\{4-[2-(dimethylamino)ethoxy]phenyl\}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene\}hydroxylamine +
0
Oximoaspergillimide
0
Viridomycin F
0
acetone oxime
0
bastadin 4
0
bastadin 5
0
bastadin 6
0
cefdinir
2
dehydroepiandrosterone 7-O-(carboxymethyl)oxime
0
diacetylmonoxime
9
indan-2-one oxime
0
indirubin-3'-monoxime
49
molnupiravir
0
nocardicin +
0
norgestimate
19
phenylpyruvic acid oxime
0
pyruvic oxime
0
verongamine
0
ximoprofen
0
Path 2
CHEBI ontology
19874
subatomic particle
19872
composite particle
19872
hadron
19872
baryon
19872
nucleon
19872
atomic nucleus
19872
atom
19872
main group element atom
19811
main group molecular entity
19811
p-block molecular entity
19811
pnictogen molecular entity
19072
nitrogen molecular entity
18974
oxime
429
ketoxime
353
(2E)-2-(hydroxyimino)isohexanoic acid
0
(2R,3R,4R,5S,6Z)-4,5-dihydroxy-6-(hydroxyimino)-2-(hydroxymethyl)piperidin-3-yl 4-O-methyl-alpha-D-maltoside
0
(2R,3R,4R,5S,6Z)-4,5-dihydroxy-6-(hydroxyimino)-2-(hydroxymethyl)piperidin-3-yl alpha-D-maltoside
0
(2Z,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-one oxime
0
(6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
0
(E,E)-bastadin 19
0
(E,Z)-bastadin 19
0
(hydroxyimino)(phenyl)acetonitrile +
22
1-(4-chlorophenyl)-2-[5-(1-pyrrolidinyl)-2-tetrazolyl]ethanone oxime
0
1-(4-methyl-2-phenyl-5-thiazolyl)ethanone oxime
0
1-[9-ethyl-6-(1-hydroxyiminoethyl)-3-carbazolyl]ethanone oxime
0
11,11-dimethyl-4,8-dimethylenebicyclo[7.2.0]undecan-5-one oxime
0
2,6-diphenyl-3-propyl-4-piperidinone oxime
0
3,3-dimethyl-1-(methylsulfanyl)butan-2-one oxime +
0
3,4,5-trihydroxypiperidin-2-one oxime
0
3-(2-allyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime
0
3-(methylsulfanyl)butan-2-one oxime +
0
3-Oxopregn-4-ene-20beta-carboxaldehyde dioxime
0
3-allyloxyestra-1,3,5(10),7-tetraene-16,17-dione dioxime
0
4-hydroxyphenylpyruvic acid oxime
0
5-(hydroxyimino)-6-oxo-5,6-dihydronaphthalene-2-sulfonic acid
0
5-methylhexan-2-one oxime
0
6-bromoindirubin-3'-oxime
36
Buccoxime
0
Cyclopentan-1-one oxime
0
Exametazime
0
FIN56
0
FK409
0
GDC-0879
0
Labienoxime
0
N(4)-hydroxycytidine +
236
N-\{5-[2-\{4-[2-(dimethylamino)ethoxy]phenyl\}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene\}hydroxylamine +
0
Oximoaspergillimide
0
Viridomycin F
0
acetone oxime
0
bastadin 4
0
bastadin 5
0
bastadin 6
0
cefdinir
2
dehydroepiandrosterone 7-O-(carboxymethyl)oxime
0
diacetylmonoxime
9
indan-2-one oxime
0
indirubin-3'-monoxime
49
molnupiravir
0
nocardicin +
0
norgestimate
19
phenylpyruvic acid oxime
0
pyruvic oxime
0
verongamine
0
ximoprofen
0